BrainsWay Ltd. – NASDAQ:BWAY
BrainsWay Ltd. stock price today
$14.32
+5.18
+56.85%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 2 hours
BrainsWay Ltd. stock price monthly change
+39.18%
month
BrainsWay Ltd. stock price quarterly change
+39.18%
quarter
BrainsWay Ltd. stock price yearly change
+40.25%
year
BrainsWay Ltd. key metrics
Market Cap | 171.57M |
Enterprise value | N/A |
P/E | -2.2 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 0.98 |
Price/Book | 0.59 |
PEG ratio | 0.02 |
EPS | -0.09 |
Revenue | 34.25M |
EBITDA | 129K |
Income | -1.65M |
Revenue Q/Q | 37.28% |
Revenue Y/Y | 32.60% |
Profit margin | -48.26% |
Oper. margin | -45.6% |
Gross margin | 73.62% |
EBIT margin | -45.6% |
EBITDA margin | 0.38% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBrainsWay Ltd. stock price history
BrainsWay Ltd. stock forecast
BrainsWay Ltd. financial statements
| Jun 2023 | 7.82M | -1.66M | -21.24% |
|---|---|---|---|
| Sep 2023 | 8.30M | -230K | -2.77% |
| Dec 2023 | 9.02M | 127K | 1.41% |
| Mar 2024 | 9.09M | 111K | 1.22% |
| Dec 2023 | 9.02M | 127K | 1.41% |
|---|---|---|---|
| Mar 2024 | 9.09M | 111K | 1.22% |
| Sep 2025 | 11.45M | 415.92K | 3.63% |
| Dec 2025 | 12.05M | 582.29K | 4.83% |
Analysts Price target
Financials & Ratios estimates
| 2022-11-18 | -0.06 | -0.15 |
|---|---|---|
| 2023-03-15 | -0.42667 | -0.24 |
| Jun 2023 | 59247000 | 17.89M | 30.2% |
|---|---|---|---|
| Sep 2023 | 59774000 | 18.55M | 31.04% |
| Dec 2023 | 62972000 | 15.31M | 24.32% |
| Mar 2024 | 65143000 | 17.30M | 26.56% |
| Jun 2023 | 995K | -1.51M | -377K |
|---|---|---|---|
| Sep 2023 | 1.35M | -506K | -56K |
| Dec 2023 | 2.47M | -35.45M | -527K |
| Mar 2024 | 3.17M | -709.99K | -589K |
BrainsWay Ltd. alternative data
| Aug 2023 | 134 |
|---|---|
| Sep 2023 | 134 |
| Oct 2023 | 134 |
| Nov 2023 | 134 |
| Dec 2023 | 134 |
| Jan 2024 | 134 |
| Feb 2024 | 134 |
| Mar 2024 | 134 |
| Apr 2024 | 134 |
| May 2024 | 134 |
| Jun 2024 | 134 |
| Jul 2024 | 134 |
BrainsWay Ltd. other data
5.71%
-11.19%
of BWAY is owned by hedge funds
1.88M
-3.38M
shares is hold by hedge funds
| Patent |
|---|
Grant Utility: Use of transcranial magnetic stimulation to modulate permeability of the blood-brain barrier Filling date: 2 Jul 2019 Issue date: 8 Feb 2022 |
Grant Utility: Electromagnetic coil assembly Filling date: 5 Feb 2019 Issue date: 28 Dec 2021 |
Application Filling date: 30 Apr 2019 Issue date: 25 Nov 2021 |
Application Filling date: 5 Feb 2019 Issue date: 15 Apr 2021 |
Grant Filling date: 30 Oct 2017 Issue date: 21 Apr 2020 |
Grant Filling date: 18 Jan 2018 Issue date: 17 Mar 2020 |
Application Filling date: 2 Jul 2019 Issue date: 26 Dec 2019 |
Application Filling date: 25 Oct 2017 Issue date: 15 Aug 2019 |
| Quarter | Transcript |
|---|---|
| Q1 2024 8 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 6 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 15 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 9 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Dr. Christopher R. von Jako Ph.D. (1969) Pres & Chief Executive Officer | $463,750 |
Mr. Hadar Levy (1974) Senior Vice President & GM of North America | $354,000 |
Mr. Christopher J. Boyer Ph.D. (1978) Vice President of Global Marketing | $146,670 |
-
What's the price of BrainsWay Ltd. stock today?
One share of BrainsWay Ltd. stock can currently be purchased for approximately $14.32.
-
When is BrainsWay Ltd.'s next earnings date?
Unfortunately, BrainsWay Ltd.'s (BWAY) next earnings date is currently unknown.
-
Does BrainsWay Ltd. pay dividends?
No, BrainsWay Ltd. does not pay dividends.
-
How much money does BrainsWay Ltd. make?
BrainsWay Ltd. has a market capitalization of 171.57M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 16.96% to 31.79M US dollars. BrainsWay Ltd. made a loss 4.2M US dollars in net income (profit) last year or -$0.24 on an earnings per share basis.
-
What is BrainsWay Ltd.'s stock symbol?
BrainsWay Ltd. is traded on the NASDAQ under the ticker symbol "BWAY".
-
What is BrainsWay Ltd.'s primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of BrainsWay Ltd.?
Shares of BrainsWay Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are BrainsWay Ltd.'s key executives?
BrainsWay Ltd.'s management team includes the following people:
- Dr. Christopher R. von Jako Ph.D. Pres & Chief Executive Officer(age: 56, pay: $463,750)
- Mr. Hadar Levy Senior Vice President & GM of North America(age: 51, pay: $354,000)
- Mr. Christopher J. Boyer Ph.D. Vice President of Global Marketing(age: 47, pay: $146,670)
-
How many employees does BrainsWay Ltd. have?
As Jul 2024, BrainsWay Ltd. employs 134 workers.
-
When BrainsWay Ltd. went public?
BrainsWay Ltd. is publicly traded company for more then 6 years since IPO on 17 Apr 2019.
-
What is BrainsWay Ltd.'s official website?
The official website for BrainsWay Ltd. is brainsway.com.
-
How can i contact BrainsWay Ltd.?
BrainsWay Ltd. can be reached via phone at +972 2 582 4030.
BrainsWay Ltd. company profile:
BrainsWay Ltd.
brainsway.comExchange:
NASDAQ
Full time employees:
134
Industry:
Medical - Devices
Sector:
Healthcare
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
Bynet Building
Jerusalem, 9777518
Jerusalem, 9777518
CIK: 0001505065
ISIN: US10501L1061
CUSIP: 10501L106
